Glaukos Corp (STU:6GJ)
€ 119 0 (0%) Market Cap: 6.82 Bil Enterprise Value: 6.73 Bil PE Ratio: 0 PB Ratio: 11.05 GF Score: 64/100

Glaukos Corp at Wells Fargo Healthcare Conference Transcript

Sep 06, 2023 / 04:45PM GMT
Release Date Price: €69.5 (+2.96%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

All right. Good afternoon, everyone. Welcome back. I'm the -- I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it's my pleasure to host this session with the management team from Glaukos. With us, we have Joe Gilliam, President and Chief Operating Officer; Alex Thurman, CFO; and Chris Lewis, Vice President of Investor Relations. In terms of format, it will be a fireside chat. If anybody has a question, please raise your hand and we will call on you. Joe, Alex and Chris, thanks for being here.

Joseph E. Gilliam
Glaukos Corporation - President & COO

Thanks for having us, Larry. Good to be here.

Questions & Answers

Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

So Joe, I wanted to start with kind of a big picture question. You guys have had good growth in the first half of this year. You're on the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot